EUVIMEDEUVIMED entdecken
Editorial

ENDPAC model for defining a high-risk group for pancreatic cancer: Strengths, limitations and the way forward

Salman Khan, Suresh T Chari

Pancreatology · 2025-12 · 25 (8) · 1404-1406

DOI: 10.1016/j.pan.2025.11.007 ↗

Kurz gefasst

Editorial in der Zeitschrift Pancreatology, 2025-12. Verfasst von Salman Khan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of Texas Southwestern, Dallas, TX, USA; Department of Internal Medicine, West Virginia University School …. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 16 Literaturangaben. Gefördert von: Pancreatic Cancer Action Network.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Internal Medicine, University of Texas Southwestern, Dallas, TX, USA; Department of Internal Medicine, West Virginia University School of Medicine, Morgantown, WV, USA.
  • Department of Gastroenterology and Hepatology, University of Texas MD Anderson Cancer Center, USA. Electronic address: stchari@mdanderson.org.

Förderung

  • Pancreatic Cancer Action Network

Zitieren

APA

Khan, S., & Chari, S. T. (2025). ENDPAC model for defining a high-risk group for pancreatic cancer: Strengths, limitations and the way forward. Pancreatology, 25(8), 1404-1406. https://doi.org/10.1016/j.pan.2025.11.007

Vancouver

Khan S, Chari ST. ENDPAC model for defining a high-risk group for pancreatic cancer: Strengths, limitations and the way forward. Pancreatology. 2025;25(8):1404-1406. doi:10.1016/j.pan.2025.11.007

BibTeX
@article{Khan2025,
  author = {Khan, Salman and Chari, Suresh T},
  title = {ENDPAC model for defining a high-risk group for pancreatic cancer: Strengths, limitations and the way forward},
  journal = {Pancreatology},
  year = {2025},
  volume = {25},
  number = {8},
  pages = {1404--1406},
  doi = {10.1016/j.pan.2025.11.007}
}
Kostenlos starten →